Purchase Order 75N98019P02549
Award Date
7/3/19
Potential Completion Date
7/17/24
Potential Value
$15K
Funding Federal Agency
National Eye Institute
Contracting Federal Agency
Office of Logisitics and Acquisition Operations
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price contract was awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization. The $10,928.00 award is for the delivery of Oxford Nanopore's DNA sequencing flow cells and reagents to support long-read sequencing activities at the agency's DNA Sequencing Core. The contract has a completion date of November 7, 2023 and does not utilize any...
This $6,678 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company that develops and provides nanopore-based electronic DNA/RNA sequencing systems. The award does not have a set-aside designation. Through this contract, Oxford Nanopore is providing its next-generation sequencing equipment, consumables, and...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, is for the provision of the company's MinION sequencing device and associated supplies. The $24,999.00 firm fixed-price Purchase Order was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), and does not have a set-aside designation. Oxford Nanopore's innovative nanopore-based sequencing platforms,...
This federal contract award was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $16,500 firm-fixed-price purchase order is for the delivery of Oxford Nanopore's next-generation genomic sequencing equipment, consumables, reagents, software licenses, and associated services. The contract does not have a set-aside designation. Oxford Nanopore Technologies Inc....
This federal contract award, valued at $17,732.00, was made by the United States Department of Agriculture (USDA) Agricultural Research Service (ARS) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the provision of various Oxford Nanopore sequencing products, including MinION flow cells, VolTRAX sequencing kits, Flongle flow kits, and flow cell wash kits. These products are to be used with the Oxford Nanopore MinION sequencing device...
This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for $21,588.00 in equipment. The contract has no set-aside designation. Oxford Nanopore Technologies Inc. is a biotechnology company that develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The company has...
This is a $12,550.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of a GridION sequencing device, with an ultimate completion date of August 1, 2025. Oxford Nanopore Technologies has secured numerous federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated...
This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The $21,835 contract is for the delivery of reagents to assist investigators working to sequence unresolved regions of the human genome. The award does not have a set-aside designation. Oxford Nanopore Technologies Inc. has been awarded several...
This federal contract award, valued at $44,838.00, was made by the National Institute on Aging (NIA), a civilian agency under the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the procurement of Promethion flow cell packs and ligation sequencing kits, which are used in Oxford Nanopore's next-generation genomic sequencing platforms. The contract is a firm fixed-price purchase order with a...
This contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Oxford Nanopore Technologies Inc. for the purchase of sequencing kits for the MinION sequencer. The $15,800.00 firm fixed price contract has a completion date of August 31, 2018 and does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a foreign-owned, for-profit biotechnology company that provides genomic sequencing...